These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27039668)

  • 21. Basophil activation by mosquito extracts in patients with hypersensitivity to mosquito bites.
    Sakakibara Y; Wada T; Muraoka M; Matsuda Y; Toma T; Yachie A
    Cancer Sci; 2015 Aug; 106(8):965-71. PubMed ID: 25990049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical categories of exaggerated skin reactions to mosquito bites and their pathophysiology.
    Tatsuno K; Fujiyama T; Matsuoka H; Shimauchi T; Ito T; Tokura Y
    J Dermatol Sci; 2016 Jun; 82(3):145-52. PubMed ID: 27177994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular lesion in a patient of chronic active Epstein-Barr virus infection with hypersensitivity to mosquito bites: vasculitis induced by mosquito bite with the infiltration of nonneoplastic Epstein-Barr virus-positive cells and subsequent development of natural killer/T-cell lymphoma with angiodestruction.
    Kanno H; Onodera H; Endo M; Maeda F; Chida S; Akasaka T; Sawai T
    Hum Pathol; 2005 Feb; 36(2):212-8. PubMed ID: 15754300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypersensitivity to mosquito bites: a unique pathogenic mechanism linking Epstein-Barr virus infection, allergy and oncogenesis.
    Asada H
    J Dermatol Sci; 2007 Mar; 45(3):153-60. PubMed ID: 17169531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.
    Wu YH; Chen HC; Hsiao PF; Tu MI; Lin YC; Wang TY
    Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
    Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
    Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions.
    Zhang Y; Nagata H; Ikeuchi T; Mukai H; Oyoshi MK; Demachi A; Morio T; Wakiguchi H; Kimura N; Shimizu N; Yamamoto K
    Br J Haematol; 2003 Jun; 121(5):805-14. PubMed ID: 12780797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroa vacciniforme and hydroa vacciniforme-like T-cell lymphoma: an uncommon event for transformation.
    Chen CC; Chang KC; Medeiros LJ; Lee JY
    J Cutan Pathol; 2016 Dec; 43(12):1102-1111. PubMed ID: 27531667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
    Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK
    Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oculomucosal and gastrointestinal involvement in Epstein-Barr virus-associated hydroa vacciniforme.
    Yamamoto T; Hirai Y; Miyake T; Yamasaki O; Morizane S; Iwatsuki K
    Eur J Dermatol; 2012; 22(3):380-3. PubMed ID: 22361979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe mosquito bite hypersensitivity, natural killer cell leukaemia, latent or chronic active Epstein-Barr virus infection and hydroa vacciniforme-like eruption.
    Tokura Y; Ishihara S; Ohshima K; Hidano A; Koide M; Seo N; Takigawa M
    Br J Dermatol; 1998 May; 138(5):905-6. PubMed ID: 9666846
    [No Abstract]   [Full Text] [Related]  

  • 32. The association of latent Epstein-Barr virus infection with hydroa vacciniforme.
    Iwatsuki K; Xu Z; Takata M; Iguchi M; Ohtsuka M; Akiba H; Mitsuhashi Y; Takenoshita H; Sugiuchi R; Tagami H; Kaneko F
    Br J Dermatol; 1999 Apr; 140(4):715-21. PubMed ID: 10233328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-CCR4 monoclonal antibody mogamulizumab for the treatment of EBV-associated T- and NK-cell lymphoproliferative diseases.
    Kanazawa T; Hiramatsu Y; Iwata S; Siddiquey M; Sato Y; Suzuki M; Ito Y; Goshima F; Murata T; Kimura H
    Clin Cancer Res; 2014 Oct; 20(19):5075-84. PubMed ID: 25117294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroa vacciniforme lymphoproliferative disorder: a retrospective study of 42 paediatric cases.
    Zhang Y; Liu Y; Xu J; Liang Y; Xu Z
    Eur J Dermatol; 2024 Apr; 34(2):144-149. PubMed ID: 38907544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of hypersensitivity to mosquito bite associated with Epstein-barr viral infection and natural killer cell lymphocytosis.
    Roh EJ; Chung EH; Chang YP; Myoung NH; Jee YK; Seo M; Kang JH
    J Korean Med Sci; 2010 Feb; 25(2):321-3. PubMed ID: 20119592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal expansion of Epstein-Barr virus (EBV)-infected γδ T cells in patients with chronic active EBV disease and hydroa vacciniforme-like eruptions.
    Wada T; Toga A; Sakakibara Y; Toma T; Hasegawa M; Takehara K; Shigemura T; Agematsu K; Yachie A
    Int J Hematol; 2012 Oct; 96(4):443-9. PubMed ID: 22886572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical hypersensitivity to mosquito bites without natural killer cell proliferative disease in an adult patient.
    Konuma T; Uchimaru K; Sekine R; Ohno N; Soda Y; Tomonari A; Ooi J; Nagamura F; Takahashi S; Iseki T; Oyaizu N; Tojo A; Asano S
    Int J Hematol; 2005 Dec; 82(5):441-4. PubMed ID: 16533749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer cell-derived large granular lymphocyte lymphoma of lung developed in a patient with hypersensitivity to mosquito bites and reactivated Epstein-Barr virus infection.
    Mizuki M; Ueda S; Tagawa S; Shibayama H; Nishimori Y; Shibano M; Asada H; Tanaka M; Nagata S; Koudera U; Suzuki K; Machii T; Ohsawa M; Aozasa K; Kitani T; Kanakura Y
    Am J Hematol; 1998 Dec; 59(4):309-15. PubMed ID: 9840912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactivation of Epstein-Barr virus in B cells of patients with chronic hepatitis C.
    Shimozuma Y; Ito T; Inokuchi M; Uchikoshi M; Miyashita M; Nozawa H; Shimazaki T; Hiroishi K; Imawari M
    J Med Virol; 2010 Dec; 82(12):2064-72. PubMed ID: 20981794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatal natural killer cell lymphoma arising in a patient with a crop of Epstein-Barr virus-associated disorders.
    Nitta Y; Iwatsuki K; Kimura H; Kojima S; Morishima T; Tsuji K; Oono T
    Eur J Dermatol; 2005; 15(6):503-6. PubMed ID: 16280311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.